Related references
Note: Only part of the references are listed.Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC) : patient-reported quality-of-life outcomes of a randomised, controlled, 3 trial
Per Fransson et al.
LANCET ONCOLOGY (2021)
Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow
Annika Mannerberg et al.
RADIATION ONCOLOGY (2020)
Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial
Elke Rammant et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2019)
The role of hypofractionated radiotherapy for the definitive treatment of localized prostate cancer: early results of a randomized trial
Petros Alexidis et al.
JOURNAL OF CANCER (2019)
Genitourinary and gastrointestinal toxicity among patients with localized prostate cancer treated with conventional versus moderately hypofractionated radiation therapy: systematic review and meta-analysis
Icaro T. Carvalho et al.
ACTA ONCOLOGICA (2018)
Optimal scheduling of hypofractionated radiotherapy for localized prostate cancer: A systematic review and metanalysis of randomized clinical trials
Giorgio Arcangeli et al.
CANCER TREATMENT REVIEWS (2018)
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline
Scott C. Morgan et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Acute and late complications after hypofractionated intensity modulated radiotherapy in prostate cancer
Takuyo Kozuka et al.
JAPANESE JOURNAL OF RADIOLOGY (2017)
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
Charles N. Catton et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Acute and late complications after hypofractionated intensity modulated radiotherapy in prostate cancer
Takuyo Kozuka et al.
JAPANESE JOURNAL OF RADIOLOGY (2017)
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
David Dearnaley et al.
LANCET ONCOLOGY (2016)
Acute Toxicity After Image-Guided Intensity Modulated Radiation Therapy Compared to 3D Conformal Radiation Therapy in Prostate Cancer Patients
Ruud C. Wortel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial
Shafak Aluwini et al.
LANCET ONCOLOGY (2015)
Efficacy and toxicity of conventionally fractionated pelvic radiation with a hypofractionated simultaneous versus conventionally fractionated sequential boost for patients with high-risk prostate cancer
Andrew M. McDonald et al.
ACTA ONCOLOGICA (2013)
Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate Cancer
Alan Pollack et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients
Darius Norkus et al.
RADIATION ONCOLOGY (2013)
Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06
Susan L. Tucker et al.
RADIOTHERAPY AND ONCOLOGY (2012)
ACUTE AND LATE TOXICITY IN A RANDOMIZED TRIAL OF CONVENTIONAL VERSUS HYPOFRACTIONATED THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY FOR PROSTATE CANCER
Giorgio Arcangeli et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Adaptive Radiation Therapy for Prostate Cancer
Michel Ghilezan et al.
SEMINARS IN RADIATION ONCOLOGY (2010)
HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY FOR CARCINOMA OF THE PROSTATE: ANALYSIS OF TOXICITY
Joanna H. Coote et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer
George van Andel et al.
EUROPEAN JOURNAL OF CANCER (2008)
An overview of nocturia and the syndrome of nocturnal polyuria in the elderly
Dean A. Kujubu et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2008)
Phase II trial of hypofractionated image-guided intensitymodulated radiotherapy for localized prostate adenocarcinoma
Jarad M. Martin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience
Patrick A. Kupelian et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Radiation proctopathy in the treatment of prostate cancer
Amit K. Garg et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy
STH Peeters et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic lymph nodes treated with high-dose radiation
CE Vargas et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Randomized trial comparing two fractionation schedules for patients with localized prostate cancer
H Lukka et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy
STK Peeters et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer
JT Wei et al.
UROLOGY (2000)
Share Paper
